Immune-Related Adverse Events Are Associated With Outcomes Among Patients With Head and Neck Cancer Receiving Immune Checkpoint Inhibitors
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Immune-related adverse events are associated with improved response, progression-free survival, and overall survival for patients with head and neck cancer receiving immune checkpoint inhibitors
Cancer 2021 Sep 21;[EPub Ahead of Print], CC Foster, MA Couey, SE Kochanny, A Khattri, RK Acharya, YC Tan, RJ Brisson, RS Leidner, TY SeiwertFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.